Genolution

Genolution Market Cap per Employee

The Market Cap per Employee of Genolution (225220.KQ) as of Oct 22, 2026 is 375.87 M KRW. In the previous year, Market Cap per Employee was 375.87 M KRW — a change of 0.00% (lower).

Market Cap per Employee

375.87 MKRW

YoY

0.00%

Last updated:

Market Cap per Employee of Genolution is 2025 375.87 M KRW. Market Cap per Employee of Genolution was 2024 375.87 M KRW. It decreases by 0.00% lower compared to the previous year.

The Genolution Market Cap per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market Cap per Employee
Date
Market Cap per Employee
Jan 1, 2018
375.87 M KRW
Jan 1, 2019
375.87 M KRW
Jan 1, 2020
375.87 M KRW
Jan 1, 2021
375.87 M KRW
Jan 1, 2022
375.87 M KRW
Jan 1, 2023
375.87 M KRW
Jan 1, 2024
375.87 M KRW
Jan 1, 2025
375.87 M KRW
The Genolution Market Cap per Employee history
YEARMarket Cap per EmployeeYoY
375.87 MKRW0.00%
375.87 MKRW0.00%
375.87 MKRW0.00%
375.87 MKRW0.00%
375.87 MKRW0.00%
375.87 MKRW0.00%
375.87 MKRW0.00%
375.87 MKRW0.00%
375.87 MKRW0.00%
375.87 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genolution Stock analysis

What does Genolution do? Genolution Inc develops automated nucleic acid extraction devices, nucleic acid extraction reagents, and molecular diagnostic products. The company also offers ribonucleic acid interference services. Its products are distributed domestically and internationally, serving customers in the biotechnology and healthcare sectors. The firm generates revenue through the sale of these products and services to research institutions, laboratories, and healthcare providers. The company's core offerings include nucleic acid extractors, reagents, and diagnostic products, which are used in molecular biology and medical diagnostics. Genolution Inc targets biotech firms, hospitals, and research facilities as key buyers of its technology. Its domestic market presence complements its international distribution channels. Genolution Inc's business model relies on selling its automated extraction devices and reagents to customers requiring efficient nucleic acid processing solutions. The company's molecular diagnostic products cater to healthcare applications, while its ribonucleic acid interference services support advanced research needs. Revenue streams are derived from both product sales and service contracts within the biotechnology industry. Genolution is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genolution stock

Market Cap per Employee of Genolution is 375.87 M KRW in 2025.

Market Cap per Employee of Genolution changed from 375.87 M KRW to 375.87 M KRW, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Market Cap per Employee Genolution since 2006 – with annual values, charts, and detailed analysis.

Market cap per employee shows the market value attributed to each employee. Technology companies typically have higher values due to intellectual capital.

Market Cap per Employee's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Market Cap per Employee's Genolution historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Genolution

All Key Metrics — Genolution